- Home
- ATYR vs UPXI Comparison
ATYR vs UPXI Comparison
Compare ATYR & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATYR | UPXI |
|---|---|---|
| Founded | 2005 | 2018 |
| Country | United States | United States |
| Employees | 58 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 77.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ATYR | UPXI |
|---|---|---|
| Price | $0.75 | $1.01 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $4.20 | $2.00 |
| AVG Volume (30 Days) | 985.5K | ★ 6.7M |
| Earning Date | 03-05-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 92.49 |
| EPS | N/A | ★ 0.76 |
| Revenue | N/A | ★ $15,811,345.00 |
| Revenue This Year | N/A | $118.99 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.41 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $0.54 |
| 52 Week High | $7.29 | $22.53 |
Technical Indicators
Market Signals| Indicator | ATYR | UPXI |
|---|---|---|
| Relative Strength Index (RSI) | 37.34 | 47.03 |
| Support Level | $0.67 | $0.54 |
| Resistance Level | $0.85 | $1.22 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 1.23 | 24.64 |
Price Performance
Historical ComparisonAbout ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via Solana. Geographically, the company generates the majority of its revenue from the United States.